Literature DB >> 2118039

Role of oxygen radicals in adriamycin-induced nephrosis.

S H Wu1, Y C Yang, Z M Wang.   

Abstract

The mechanism of cellular processes responsible for proteinuria induced by adriamycin (ADR) remains unclear. In this study, we examined whether oxygen radicals contribute to the development of proteinuria in ADR-induced nephrosis. The peak concentration of malondialdehyde (MDA) of kidney was found on 8th day after ADR treatment in rats. ADR-treated rats received either superoxide dismutase (SOD, scavenger of O2-, catalase (CAT, scavenger of . H2O2) or dimethyl sulfoxide (DMSO, scavenger of OH). The SOD, CAT or DMSO treated groups had a significant suppression of urinary protein excretion, serum and renal MDA compared to ADR control group. There were also less severe renal morphologic changes in the former three groups vs the ADR controls. These data provide indirect evidence that oxygen radicals generated by ADR are important mediators of ADR-induced proteinuria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118039

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varlakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

2.  In vitro modulation of interleukin-1 beta secretion by cultured rat doxorubicin-stimulated whole glomeruli and dissociated mesangial glomerular cells.

Authors:  T Bricio; A Molina; A Martin; F Mampaso
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

3.  Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.

Authors:  Benjamin L Barthel; Zhiyong Zhang; Daniel L Rudnicki; Christopher D Coldren; Margaret Polinkovsky; Hengrui Sun; Gary G Koch; Daniel C F Chan; Tad H Koch
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.